Related Experiment Videos
[Diffuse liver parenchymal diseases: the value of MRI compared to sonography and CT]
Abstract:
29 patients with diffuse liver disease were examined by ultrasound, CT and MRI. MRI imaging was performed using T1-and t2-weighted spin-echo-sequences and fast gradient-echo-sequences. The paramagnetic contrast agent Gd-DTPA was applied intravenously (0.1 mmol/kg). In all patients with hepatitis MRI enabled exact liver biopsy by delineation of inflammatory changes in cases of chronic or focal hepatitis. CT and ultrasound were superior to MRI in the detection of focal or diffuse fatty degeneration. However, MRI enabled an exact differentiation of fatty changes from neoplasm. In cases of fibrotic changes the most accurate findings could be shown by MRI. In patients suffering from hemochromatosis MRI supplied additional information compared to CT and ultrasound revealing significant reduction of signal intensity due to reinforced enhancement of iron. Concerning Wilson's disease MRI showed a characteristic pattern of parenchymal changes. The application of Gd-DTPA in cases of diffuse liver disease adds supplementary information about perfusion of liver parenchyma, but its value for diagnostic accuracy is only secondary.
Insights
Magnetic Resonance Imaging (MRI) offers precise diagnosis for diffuse liver diseases like hepatitis and Wilson's disease. While CT and ultrasound excel at detecting fatty changes, MRI accurately differentiates them from neoplasms and assesses fibrotic changes.
Area of Science:
- Radiology
- Medical Imaging
- Hepatology
Background:
- Diffuse liver diseases encompass a range of conditions affecting liver function and structure.
- Accurate diagnosis is crucial for effective management and treatment of liver pathologies.
- Multimodality imaging plays a key role in evaluating liver parenchyma.
Purpose of the Study:
- To evaluate the diagnostic accuracy of Magnetic Resonance Imaging (MRI) compared to Computed Tomography (CT) and ultrasound in patients with diffuse liver disease.
- To assess the specific contributions of MRI in differentiating various liver conditions, including hepatitis, fatty degeneration, fibrosis, hemochromatosis, and Wilson's disease.
Main Methods:
- Twenty-nine patients with diffuse liver disease underwent examination using ultrasound, CT, and MRI.
- MRI protocols included T1- and T2-weighted spin-echo and fast gradient-echo sequences.
- Intravenous administration of the paramagnetic contrast agent Gd-DTPA (0.1 mmol/kg) was performed.
Main Results:
- MRI accurately delineated inflammatory changes in hepatitis, aiding liver biopsy.
- CT and ultrasound were superior in detecting fatty degeneration, but MRI differentiated it from neoplasms.
- MRI provided the most accurate findings for fibrotic changes and offered additional diagnostic information for hemochromatosis and Wilson's disease.
Conclusions:
- MRI is a valuable tool for diagnosing diffuse liver diseases, particularly for inflammatory, fibrotic, and iron-related conditions.
- While CT and ultrasound have advantages in detecting fatty changes, MRI excels in characterization and differentiation.
- Gd-DTPA contrast enhances perfusion assessment but has a secondary role in overall diagnostic accuracy for diffuse liver disease.